2025 Updates to ESC/EAS Dyslipidaemia Management Guidelines

Created using ChatSlide

Join us for an enlightening panel discussion addressing the latest advancements in cardiovascular guideline development. We will explore the purpose and scope of new evidence-based recommendations and expert declarations. Gain insights into key updates, including innovative risk estimation tools and therapies. Delve into the influence of subclinical atherosclerosis, lipoprotein(a) considerations, and hypertriglyceridaemia management on cardiovascular risk. The session will also cover the...